Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).
Cafaro A, Foca F, Nanni O, Chiumente M, Coppola M, Baldo P, Orzetti S, Enrico F, Ladisa V, Lerose R, Nardulli P, Maiolino P, Gradellini F, Gasbarro AR, Carrucciu G, Provasi R, Cappelletto PC, Pasqualini A, Vecchia S, Veraldi M, De Francesco AE, Crinò L, Delmonte A, Masini C. Cafaro A, et al. Among authors: de francesco ae. Front Oncol. 2024 Mar 27;14:1351995. doi: 10.3389/fonc.2024.1351995. eCollection 2024. Front Oncol. 2024. PMID: 38601759 Free PMC article.
Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate-High Risk: A Cost-Effectiveness Analysis.
Bellone M, Pradelli L, Molica S, De Francesco AE, Ghislieri D, Guardalben E, Caputo A. Bellone M, et al. Among authors: de francesco ae. Clinicoecon Outcomes Res. 2021 Jul 22;13:661-671. doi: 10.2147/CEOR.S317885. eCollection 2021. Clinicoecon Outcomes Res. 2021. PMID: 34321898 Free PMC article.
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy.
Roberti R, Iannone LF, Palleria C, De Sarro C, Spagnuolo R, Barbieri MA, Vero A, Manti A, Pisana V, Fries W, Trifirò G, Naturale MD, Larussa T, De Francesco AE, Bosco V, Donato di Paola E, Citraro R, Luzza F, Bennardo L, Rodinò S, Doldo P, Spina E, Russo E, De Sarro G. Roberti R, et al. Among authors: de francesco ae. Curr Med Res Opin. 2020 Sep;36(9):1457-1463. doi: 10.1080/03007995.2020.1786681. Epub 2020 Jul 27. Curr Med Res Opin. 2020. PMID: 32573307
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study.
Iannone LF, Bennardo L, Palleria C, Roberti R, De Sarro C, Naturale MD, Dastoli S, Donato L, Manti A, Valenti G, D'Amico D, D'Attola S, De Francesco AE, Bosco V, Donato Di Paola E, Nisticò SP, Citraro R, Russo E, De Sarro G. Iannone LF, et al. Among authors: de francesco ae. PLoS One. 2020 Nov 3;15(11):e0241575. doi: 10.1371/journal.pone.0241575. eCollection 2020. PLoS One. 2020. PMID: 33141869 Free PMC article.
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region.
Gagliardi A, Iaquinta FS, Grembiale RD, De Sarro C, Fabiano A, Fraija D, Palleria C, Romeo R, De Francesco AE, Naturale MD, Citraro R, Gallelli L, Leo A, De Sarro G. Gagliardi A, et al. Among authors: de francesco ae. Pharmaceutics. 2022 Oct 28;14(11):2328. doi: 10.3390/pharmaceutics14112328. Pharmaceutics. 2022. PMID: 36365146 Free PMC article.
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study.
Tallarico M, Palleria C, Ruffolo L, Spagnuolo R, Naturale MD, De Francesco AE, De Sarro C, Romeo R, Citraro R, Doldo P, Abenavoli L, Gallelli L, Luzza F, Leo A, De Sarro G. Tallarico M, et al. Among authors: de francesco ae. Pharmaceutics. 2022 Nov 13;14(11):2449. doi: 10.3390/pharmaceutics14112449. Pharmaceutics. 2022. PMID: 36432640 Free PMC article.
Pharmacovigilance in Italy: An overview.
Mazzitello C, Esposito S, De Francesco AE, Capuano A, Russo E, De Sarro G. Mazzitello C, et al. Among authors: de francesco ae, de sarro g. J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S20-8. doi: 10.4103/0976-500X.120942. J Pharmacol Pharmacother. 2013. PMID: 24347976 Free PMC article. Review.
Pattern of triptans use: a retrospective prescription study in Calabria, Italy.
Scuteri D, Adornetto A, Rombolà L, Naturale MD, De Francesco AE, Esposito S, Zito M, Morrone LA, Bagetta G, Tonin P, Corasaniti MT. Scuteri D, et al. Among authors: de francesco ae. Neural Regen Res. 2020 Jul;15(7):1340-1343. doi: 10.4103/1673-5374.272630. Neural Regen Res. 2020. PMID: 31960822 Free PMC article.
Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources.
Perrone V, Veronesi C, Dovizio M, Ancona DD, Andretta M, Bartolini F, Cavaliere A, Chinellato A, Ciaccia A, Cillo M, De Francesco A, Enieri N, Ferrante F, Gentile S, Procacci C, Ubertazzo L, Vercellone A, Lucatelli D, Procaccini M, Degli Esposti L. Perrone V, et al. Clinicoecon Outcomes Res. 2022 Jul 28;14:513-521. doi: 10.2147/CEOR.S361692. eCollection 2022. Clinicoecon Outcomes Res. 2022. PMID: 35923519 Free PMC article.
17 results